Demethoxycurcumin ameliorates rotenone-induced toxicity in rats.

Demethoxycurcumin ameliorates rotenone-induced toxicity in rats. Front Biosci (Elite Ed). 2019 Jan 01;11:1-11 Authors: Ramkumar M, Rajasankar S, Swaminathan Johnson WM, Prabu K, Venkatesh Gobi V Abstract Rotenone, an environmental toxin, is used to induce neurodegeneration in both the cellular and animal model of Parkinson's disease. Demethoxycurcumin (DMC), derivative of curcumin has been reported to have antioxidant and anti-inflammatory characteristics in in vitro and in vivo PD conditions. The present study was aimed to evaluate the efficacy of DMC in the management of neurodegeneration in PD. Male Wistar rats were radomized and divided into control, rotenone, DMC +rotenone and rotenone alone treated animals. Pre-treatment with DMC one hour prior to the rotenone injection, attenuated the motor and non-motor deficits. Western blot analysis indicated that the administration of DMC to PD rats eased the protein expression of dopaminergic and apoptotic indices. These findings showed that DMC effects on ameliorating the PD symptoms induced by rotenone might be associated with the neuroprotective and antioxidant effects of this compound. PMID: 30468633 [PubMed - in process]
Source: Frontiers in Bioscience - Elite - Category: Biomedical Science Tags: Front Biosci (Elite Ed) Source Type: research

Related Links:

Conclusion The patients in the DAT-positive group might have prodromal symptoms that were worsened by neuroleptic drugs. The results of detailed history-taking and neurological findings seem to indicate cases of compromised dopaminergic transmission before the administration of neuroleptic drugs. PMID: 32062624 [PubMed - in process]
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research
Conclusion: More data concerning the safety of antiparkinsonian drugs in PD treatment, as well as the effect of pregnancy on parkinsonian symptoms are needed. According to the current state of the art, L-DOPA therapy should be considered preferable to other drugs during pregnancy.
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Condition:   Parkinson Disease Intervention:   Device: Auditive cueing Sponsors:   Ceriter Nederland BV;   Ziekenhuis Oost Limburg (ZOL) Hospital Genk, Belgium Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Parkinson Disease Intervention:   Drug: Lithium Sponsor:   University at Buffalo Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Parkinson Disease;   Cognitive Impairment, Mild;   Speech Interventions:   Diagnostic Test: Cognitive Battery;   Behavioral: Voice, Speech and Language Analysis;   Behavioral: Questionnaires and Clinical Assessments;   Genetic: DNA Analysis Sponsors:   University of Massachusetts, Worcester;   Sonde Health, Inc.;   Massachusetts Institute of Technology/Lincoln Labs;   Boston University;   VA Puget Sound Health Care System Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Parkinson Disease Intervention:   Drug: Lithium Sponsor:   University at Buffalo Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Parkinson Disease;   Cognitive Impairment, Mild;   Speech Interventions:   Diagnostic Test: Cognitive Battery;   Behavioral: Voice, Speech and Language Analysis;   Behavioral: Questionnaires and Clinical Assessments;   Genetic: DNA Analysis Sponsors:   University of Massachusetts, Worcester;   Sonde Health, Inc.;   Massachusetts Institute of Technology/Lincoln Labs;   Boston University;   VA Puget Sound Health Care System Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Parkinson Disease Intervention:   Device: Auditive cueing Sponsors:   Ceriter Nederland BV;   Ziekenhuis Oost Limburg (ZOL) Hospital Genk, Belgium Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Publication date: Available online 17 February 2020Source: Neuroscience &Biobehavioral ReviewsAuthor(s): Zhike Zhou, Yifan Liang, Xiaoqian Zhang, Junjie Xu, Jueying Lin, Rongwei Zhang, Kexin Kang, Huiling Qu, Chuansheng Zhao, Mei ZhaoAbstractBackgroundThe aim of this meta-analysis is to evaluate the association of fibrinogen with risk of dementia and its subtypes.MethodsEmbase, Pubmed and Web of Science were retrieved systematically up to February 2019. Standard mean difference (SMD) with 95% confidence intervals was estimated using random-effects models.ResultsSixteen studies involving 3,649 participants were summariz...
Source: Neuroscience and Biobehavioral Reviews - Category: Neuroscience Source Type: research
For a variety of sporadic neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, it is well-established that ethnicity do affect the disease phenotypes. However, how the ethnicity could contribute to the clinical symptoms and disease progressions in monogenetic disorders, such as spinocerebellar ataxia type 3 (SCA3), remains less studied.
Source: Parkinsonism and Related Disorders - Category: Neurology Authors: Source Type: research
More News: Antidoxidants | Biomedical Science | Brain | Environmental Health | Neurology | Parkinson's Disease | Study | Toxicology | Turmeric